Ensign Peak Advisors’s Relay Therapeutics RLAY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-64,900
| Closed | -$170K | – | 1716 |
|
|
2025
Q1 | $170K | Hold |
64,900
| – | – | ﹤0.01% | 1678 |
|
|
2024
Q4 | $267K | Buy |
64,900
+9,450
| +17% | +$38.9K | ﹤0.01% | 1686 |
|
|
2024
Q3 | $393K | Hold |
55,450
| – | – | ﹤0.01% | 1657 |
|
|
2024
Q2 | $362K | Buy |
55,450
+10,850
| +24% | +$70.7K | ﹤0.01% | 1666 |
|
|
2024
Q1 | $370K | Sell |
44,600
-2,250
| -5% | -$18.7K | ﹤0.01% | 1672 |
|
|
2023
Q4 | $516K | Buy |
46,850
+7,950
| +20% | +$87.5K | ﹤0.01% | 1654 |
|
|
2023
Q3 | $327K | Hold |
38,900
| – | – | ﹤0.01% | 1675 |
|
|
2023
Q2 | $489K | Hold |
38,900
| – | – | ﹤0.01% | 1640 |
|
|
2023
Q1 | $641K | Buy |
+38,900
| New | +$641K | ﹤0.01% | 1553 |
|
|
2022
Q4 | – | Sell |
-16,870
| Closed | -$377K | – | 2136 |
|
|
2022
Q3 | $377K | Buy |
16,870
+12,210
| +262% | +$273K | ﹤0.01% | 1603 |
|
|
2022
Q2 | $78K | Hold |
4,660
| – | – | ﹤0.01% | 2012 |
|
|
2022
Q1 | $139K | Hold |
4,660
| – | – | ﹤0.01% | 1963 |
|
|
2021
Q4 | $143K | Buy |
+4,660
| New | +$143K | ﹤0.01% | 1999 |
|